INTRODUCTION
Piglets at weaning are subjected to dietary, environmental and physiological stress, which may raise the risk of diarrhea or growth retardation. These problems occur owing to the changes of morphology and enzyme activities in the porcine small intestine after weaning (Fan et al., 2002; Hampson, 1986; Kenworthy, 1976) . The intestine digestive enzyme secretion and modulate jejunal villus morphology both in neonatal (Zijlstra et al., 1994) and weaned pigs (Jaeger et al., 1990; Lee et al., 2006) . In our previous trial, diets supplemented with 0, 0.5, 1.0, or 1.5 mg pEGF /kg diet have found that piglets supplemented with 1.0 to 1.5 mg pEGF /kg diet could stimulate jejunal alkaline phosphatase (ALP) and maltase mRNA expression and lactase activities (Lee et al., 2007) .
On the other hand, glutamine (Gln) is the most abundant free amino acid in sow's milk (Wu and Knabe, 1994) and is a major nutrient for intestinal epithelial cells (Wu et al., 1995) . The ingested Gln can be further metabolized to α-ketoglutarate and amide group, which is incorporated into the Krebs cycle to supply energy and synthesize purine, pyrimidines in the intestinal cells (Krebs, 1980; Wu et al., 1995) . Diets supplemented with Gln might enhance the intestinal growth and immune responses in 21-day weaned pigs (Lee et al., 2003a; Lee et al., 2003b) . Furthermore, EGF and Gln have been demonstrated to be a synergistic effect on small intestinal function of the septic rats (Ardawi, 1992; Ko et al., 1993) . However, dietary supplementation with EGF and Gln on the growth performance and the digestive tract development of early-weaned piglets has not been explored yet. This study attempted to understand whether dietary pEGF and Gln supplementation enhances the growth and function of the gastrointestinal tract in earlyweaned piglets.
MATERIALS AND METHODS

Animals and diets
All pigs used in this study were the offspring of either Yorkshire or Landrace sows crossed with Duroc boar. Piglets were weaned at 14±1 day of age, and fed a cornsoybean meal-whey basal diet supplemented with either inclusion of 1.0 mg pEGF supernatant /kg diet or 0.5% Gln (Ajinomoto, Tokyo, Japan) both alone and in combination. pEGF from the fermentative supernatant of transformed yeast coding porcine EGF (pEGF) gene. Briefly, the Pichia pastoris strain was transformed with pEGF gene, and was then grown in buffered methanol-complex medium with a glass bioreactor as previously described for the production and quantification of recombinant pEGF (Lee et al., 2006) . The concentration of pEGF in the supernatant was about 800 μg/ml using ELISA assay. All nutrients met National Research Council standards (NRC, 1998) . Table 1 presents the diet formulation and its nutrient composition. This experiment was performed at the National Ilan University and received prior approval from the institution's Animal Protocol Review Committee. The treatment, housing, husbandry, and slaughtering conditions adhered to current Republic of China guidelines.
Animal treatment
Ninety-six piglets from fourteen litters were assigned a dietary treatment based on sex and litter origin. Six piglets per pen with four replicates were housed in a nursery room for a 28 days experimental period. The nursery room temperature was maintained at 26°C. Feed and water were given ad libitum. Body weight and feed intake were recorded weekly to evaluate ADG, ADFI, and gain/feed. On day 14, two piglets per replicate were sacrificed and gastrointestinal tract samples were collected. After preanesthesia with thiamylal sodium 25 mg/kg body weight i.v., a mixture of 4% halothane and 96% oxygen for surgical anesthesia was administered by facemask. Stomach tissue from the antrum and pancreases were collected immediately after anesthesia. Next, the intestinal tract samples at jejunum and ileum were opened longitudinally, flushed with ice-cold phosphate buffer solution and blotted to eliminate excess fluid. Additionally, the dissected samples were fixed with 2.5% glutaraldehyde for the evaluations of villus-crypt morphology. The mucosal samples were obtained by scraping each intestinal tract tissue with a glass slide. Finally, these mucosa scrapings were placed into preweighed cryovials, weighed and then frozen in liquid nitrogen to assay DNA, protein and digestive enzyme activities. On day 28, all piglets were bled to analyze peripheral blood mononuclear cells (PBMC) proliferation and serum IgA.
Preparation and chemical analysis of samples
All chemicals (unless otherwise notes) were obtained from Sigma Chemical Co. (St. Louis, MO, USA). The intestinal samples were embedded in paraffin using the method outlined by Spurr (1969) , sectioned at 6 μm thickness and stained with hematoxylin and eosin following light microscopy examination (BX50, Olympus, Tokyo, Japan). The average villus height and crypt depth were determined from 15 well-oriented, intact villi in a blind fashion. Frozen mucosa samples were homogenized on ice in saline with 0.1% triton X-100 using a motor-driven homogenizer (Pro 200, PRO Sci., CT, USA) and a polytron homogenizer. The mucosa DNA concentration was measured according to the method as Labarca and Paigen (1980) described. The protein concentration in each sample was measured using a commercial bicinchoninic acid (BCA) protein assay kit (Pierce, IL, USA). Blood samples were drawn from the piglets and centrifuged at 2,000×g 15 min for serum collection. Serum IgA was determined using commercial ELISA kit (Bethyl, TX, USA), which serum was diluted 1,000 fold to meet the reagents supplied by the manufacturer.
Stomach mucosal pepsin activity (EC 3. 4. 23. 1) was determined by measuring the hydrolysis rate of haemoglobin (Rick and Fritsch, 1974) . Before the pepsin activity assay, the pepsinogen in the homogenate was activated by incubating at 4°C for 10 min with 0.1 M HCl at pH 2.0. The pancreatic trypsin (EC 3. 4. 21. 4) and chymotrypsin (EC 3. 4. 21. 1) activities were measured following the methods outlined by Geiger (1984) and Geiger and Fritz (1984) . Trypsinogen and chymotrypsinogen in the homogenates were activated with enterokinase at a concentration of 4 mg/ml and incubated at 4°C for 24 h. Trypsin and chymotrypsin activities were determined by measuring the hydrolysis rates of benzoyl-Larginine-p-nitroanilide and of N-succinyl-L-phenyl-alaninep-nitroanilide, respectively. The jejunal and ileal mucosa disaccharidase activities were determined as described by Petersen et al. (2002) . Maltose (300 mM), sucrose (375 mM) and lactose (56 mM) dissolved in sodium malate buffer (62.5 mM, pH 6.0) were employed as substrates for maltase activity (EC 3. 2. 1. 20), sucrase (EC 3. 2. 1. 48) and lactase (EC 3. 2. 1. 23), respectively. Alkaline phosphatase activity (EC 3. 1. 3. 1) was determined using colorimetric assay with a commercial assay kit (Roche, Basal, Switzerland).
The PBMC proliferation was measured by incorporating 3 H-thymidine into cells as previously described in Lee et al. (2003a) . Brief, the lymphocyte cells from blood were centrifugally isolated on a cushion of Ficoll-hypaques (GE Healthcare, Buckinghamshire, UK). The cells were then washed with Roswell Park Memorial Institute-1640 (RPMI-1640) medium and cultured at a concentration of 1×10 5 cells/well triplicate in an RPMI-1640 with 10% fetal bovine serum and 100 U/ml penicillin culture medium (Gibco, Invitrogen, CA, USA) at 37°C for 72 h in 5% CO 2 and 95% air. The culture medium contained 5 μg/ml concanavalin A (Con A), 10 μg/ml phytohemagglutinin (PHA), or 5 μg/ml pokeweed mitogen (PWM) to determine the lymphocyte response to mitogen stimulation. Lymphocyte proliferation was pulsed with 0.5 μCi/well 3 H-thymidine (Specific activity 80Ci /mmol, GE Healthcare) for 18 h, and was terminated by harvesting cells onto glass fiber filters using an automatic cell harvester (Packard, CT, USA). Filters were immersed in a cocktail after drying, and radioactivity was measured using a microplate scintillation and luminescence counter (Packard). Stimulation index was calculated as counts per minute (cpm) of radioactivity in the presence of a mitogen/cpm of radioactivity compared with the absence of mitogen as a basal treatment.
Statistical analysis
Experimental data were analyzed as a factorial design using the GLM procedures of SAS (SAS, 1999) . When a significant F-value for treatment means (p<0.05) was observed in the ANOVA, treatment means were compared with Duncan's multiple range test (Duncan, 1955) . The individual pigs were the experimental units, except the feed and feed efficiency data of per pen were as the experiment units.
RESULTS
One piglet was dead and diarrhea occasionally occurred that had no difference among diet treatments throughout the experimental period. Table 2 illustrates the effects of dietary treatments on growth performance of early-weaned piglets. Diets supplemented with pEGF and Gln failed to influence the ADG, ADFI, and feed efficiency during the 14 or 28 days of testing. Dietary treatments also did not affect on the stomach, pancreas, liver, kidney, spleen or small intestine weights (data not shown). Table 3 illustrates the effects of dietary treatments on DNA and the protein contents of stomach mucosa, pancreas, and jejunal mucosa on day 14 of experiment. Diets supplemented with pEGF or Gln had no effect on DNA or protein contents in these tissues. By contrast diets supplemented with Gln was increased the gastric (p = 0.08) and jejunal mucosa (p = 0.08) protein levels and jejunal mucosa DNA content (p = 0.09) but did not reach a significant level. Moreover, diets supplemented with pEGF or Gln alone was increased the pancreas DNA (p = 0.07), but had a decreased tendency in pEGF+Gln treatment pigs. Diets supplemented with pEGF and Gln failed to affect the villus height, crypt depth, or the villus height/crypt depth ratio in the jejunum and ileum (data not shown). Table 4 illustrates the effects of dietary treatments on the gastrointestinal tract enzyme activities. Diets supplemented with pEGF or Gln had no effect on gastric pepsin activity. The pepsin activity of control, pEGF, Gln, and pEGF+Gln was 311.1, 301.4, 313.8, and 339.0 μmol/mg protein/min, respectively. Diets supplemented with pEGF and Gln increased the pancreatic chymotrypsin activity, but did not affect the trypsin activity. Diets supplemented with pEGF also increased the jejunal ALP, sucrase, lactase, and maltase activities (p<0.05). However, dietary Gln supplementation or the interactive effect of pEGF and Gln did not affect these enzyme activities. Table  5 illustrates the effects of diets supplemented with pEGF and Gln on the immune responses of early-weaned piglets on day 28 of experiment. Pigs fed Gln diet had a higher level of serum IgA (p<0.05) and PBMC proliferation without mitogen stimulation (p<0.05) and with Con A (p = 0.07) and PHA (p<0.05) stimulation. Diets supplemented with pEGF failed to affect serum IgA or PBMC proliferation of early-weaned pigs. 
DISCUSSION
Previous reports have found that EGF can increase the absorption of GLN (Salloum et al., 1993; Hardin et al., 1996) . This factorial design work attempted to investigate the effects of pEGF and Gln on the growth performance, intestine development and immune response of early weaning piglets particular in the interactive effect of pEGF and Gln. Therefore, the chose dosage of pEGF and Gln was low in this experiment and the results focused on the 14 days after weaning that is critical period for the intestinal development of piglets (Bianchi et al., 1992) . However, dietary pEGF and Gln supplementation did not show significantly interactive effect. Interestingly, dietary pEGF elevated intestinal enzyme activity and dietary Gln supplement increased serum IgA and PBMC proliferation, respectively, but did not alter the growth performance. The result is associated with the rat study that EGF and Gln show no synergistic effect on enzyme activities, and the increase of EGF administration (i.v.) in the intestinal sucrase and maltase activities is more efficient than that of Gln administration (Ardawi, 1992) .
In present study, the average amount of pEGF consumption of each piglet was 240 and 714 μg/d during day 0 to 14 and day 15 to 28, respectively. Dietary pEGF supplement increased (p<0.05) the pancreatic chymotrypsin and jejunal enzyme (ALP, sucrase, lactase and maltase) activities, but did not influence the gastric pepsin or pancreatic trypsin activity. The result of pepsin activity is similar to the previous study that early-weaned piglets fed 0.5 mg pEGF/kg diet could enhance the gastric pepsin activity and return to the control level in the adding amount exceed 1.0 mg pEGF/kg diet (Lee et al., 2007) . Literatures has been well demonstrated that EGF enhances the intestinal brush border enzyme activity (Carpenter and Cohen, 1990; Jaeger et al., 1990; Zijlstra et al., 1994; Wong et al., 1999; Lee et al., 2007) . Previous report has indicted that administration with high dose (372 μg/d) EGF in 21 days weaned piglets for three consecutive days, but not with low dose (124 μg/d), can elevate jejunal disaccharidases (sucrase and lactase) activities (Jaeger et al., 1990) . Moreover, our previous study has found that dietary supplemented with 193 μg pEGF/d could enhance the mRNA expression and activity of these enzymes (Lee et al., 2007) . In this work, oral administration 240 μg pEGF/d should be sufficient to augment the enzyme activity of piglets. And we also found that dietary pEGF enhancing effect on the jejunal enzyme activity was more effective than on ileal enzyme activity. This may be attributed to orally EGF treatment faced destruction by the digestive hydrolysis in the gastrointestinal tract with some loss before reaching to ileum (Shen and Xu, 1996) . Recently, pEGF possesses the increase of nutrients absorption has been reported (Wolfgang et al., 2003) . However, the elevation of intestinal enzyme activity with dietary pEGF supplement did not result in improvement of growth performance in this study. The improvement of digestibility and absorption may be insufficient to leading the growth of piglets. Dietary pEGF supplementation did not affect growth, mucosa DNA and protein contents, or intestinal villus morphology of early-weaned piglets in this trial. This finding is also agreed with other reports (James et al., 1987; Jaeger et al., 1990 ). Our previous work in feeding 14 days weaned piglets for 28 days has found that pEGF (541 μg/d) does not change mucosal DNA content but expand villus crypt depth in jejunum (Lee et al., 2006) . Conversely, feeding pEGF (240 μg/d) to weaning piglet for 14 days did not observe any different morphological change in this experiment. This discrepancy is probably attributed to the dosage effect on morphological change.
Dietary Gln supplement did not promote growth performance during the initial 14 or 28 days post-weaning and this finding is consistent to the previous works with piglets weaned at 14 days (Lee et al., 2002) , 21 days (Lee et al., 2003b) , or 28 days (Zhou et al., 2006) . Dietary Gln supplementation raised the jejunal crypt depth on day 14 of the trial, but did not change the ratio of villus height to crypt depth. The level of Gln (0.5%) used in this study was lower than that in previous trial. One percent of Gln could increase the villus height and the DNA and protein contents in the small intestinal mucosa (Lee et al., 2003b) . Dietary Gln supplement did not affect on digestive enzyme activity is associated with the rat experiment (Li et al., 2004; Hou et al., 2006) . Dietary Gln supplementation increased serum IgA levels on day 28 (p<0.05). This result was agreed with our previous works, dietary Gln supplement tended to increase the concentration of plasma and bile IgA of weaned pigs (Lee et al., 2002; Lee et al., 2003b) . In this study, Gln supplementation also increased the PBMC proliferation in early-weaned piglets compared with the control group. Inclusion of Gln is also increased the proliferation of PBMC, mesenteric lymph node, and splenocytes in normal and infected weaned piglets (Yoo et al., 1997; Lee et al., 2003a) . Therefore, Gln performs a specific and unique role in the immune response process.
IMPLICATIONS
Diet supplemented with recombinant yeast cultures containing enriched porcine epidermal growth factor improves digestive enzyme activity in weaned piglets. Dietary glutamine supplementation stimulates the immune responses in early-weaned piglets. However, combined supplementation of porcine epidermal growth factor and glutamine does not show a synergistic effect on the intestinal development in early-weaned piglets.
